Regenerative medicine for oesophageal reconstruction after cancer treatment

Removal of malignant tissue in patients with oesophageal cancer and replacement with autologous grafts from the stomach and colon can lead to problems. The need to reduce stenosis and anastomotic leakage after oesophagectomy is a high priority. Developments in tissue-engineering methods and cell-she...

Full description

Saved in:
Bibliographic Details
Main Authors: Chian, Kerm Sin, Leong, Meng Fatt, Kono, Koji
Other Authors: School of Mechanical and Aerospace Engineering
Format: Article
Language:English
Published: 2015
Subjects:
Online Access:https://hdl.handle.net/10356/82779
http://hdl.handle.net/10220/25831
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-82779
record_format dspace
spelling sg-ntu-dr.10356-827792023-03-04T17:14:06Z Regenerative medicine for oesophageal reconstruction after cancer treatment Chian, Kerm Sin Leong, Meng Fatt Kono, Koji School of Mechanical and Aerospace Engineering DRNTU::Science::Medicine::Tissue engineering Removal of malignant tissue in patients with oesophageal cancer and replacement with autologous grafts from the stomach and colon can lead to problems. The need to reduce stenosis and anastomotic leakage after oesophagectomy is a high priority. Developments in tissue-engineering methods and cell-sheet technology have improved scaffold materials for oesophageal repair. Despite the many successful animal studies, few tissue-engineering approaches have progressed to clinical trials. In this Review, we discuss the status of oesophagus reconstruction after surgery. In particular, we highlight two clinical trials that used decellularised constructs and epithelial cell sheets to replace excised tissues after endoscopic submucosal dissection or mucosal resection procedures. Results from the trials showed that both decellularised grafts and epithelial-cell sheets prevented stenosis. By contrast, animal studies have shown that the use of tissue-engineered constructs after oesophagectomy remains a challenge. ASTAR (Agency for Sci., Tech. and Research, S’pore) Accepted Version 2015-06-08T06:36:33Z 2019-12-06T15:05:23Z 2015-06-08T06:36:33Z 2019-12-06T15:05:23Z 2015 2015 Journal Article Chian, K. S., Leong, M. F., & Kono, K. (2015). Regenerative medicine for oesophageal reconstruction after cancer treatment. The lancet oncology, 16(2), e84-e92. 1470-2045 https://hdl.handle.net/10356/82779 http://hdl.handle.net/10220/25831 10.1016/S1470-2045(14)70410-3 en The lancet oncology © 2015 Elsevier. This is the author created version of a work that has been peer reviewed and accepted for publication by The Lancet Oncology, Elsevier. It incorporates referee’s comments but changes resulting from the publishing process, such as copyediting, structural formatting, may not be reflected in this document. The published version is available at: [http://dx.doi.org/10.1016/S1470-2045(14)70410-3]. 9 p. application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic DRNTU::Science::Medicine::Tissue engineering
spellingShingle DRNTU::Science::Medicine::Tissue engineering
Chian, Kerm Sin
Leong, Meng Fatt
Kono, Koji
Regenerative medicine for oesophageal reconstruction after cancer treatment
description Removal of malignant tissue in patients with oesophageal cancer and replacement with autologous grafts from the stomach and colon can lead to problems. The need to reduce stenosis and anastomotic leakage after oesophagectomy is a high priority. Developments in tissue-engineering methods and cell-sheet technology have improved scaffold materials for oesophageal repair. Despite the many successful animal studies, few tissue-engineering approaches have progressed to clinical trials. In this Review, we discuss the status of oesophagus reconstruction after surgery. In particular, we highlight two clinical trials that used decellularised constructs and epithelial cell sheets to replace excised tissues after endoscopic submucosal dissection or mucosal resection procedures. Results from the trials showed that both decellularised grafts and epithelial-cell sheets prevented stenosis. By contrast, animal studies have shown that the use of tissue-engineered constructs after oesophagectomy remains a challenge.
author2 School of Mechanical and Aerospace Engineering
author_facet School of Mechanical and Aerospace Engineering
Chian, Kerm Sin
Leong, Meng Fatt
Kono, Koji
format Article
author Chian, Kerm Sin
Leong, Meng Fatt
Kono, Koji
author_sort Chian, Kerm Sin
title Regenerative medicine for oesophageal reconstruction after cancer treatment
title_short Regenerative medicine for oesophageal reconstruction after cancer treatment
title_full Regenerative medicine for oesophageal reconstruction after cancer treatment
title_fullStr Regenerative medicine for oesophageal reconstruction after cancer treatment
title_full_unstemmed Regenerative medicine for oesophageal reconstruction after cancer treatment
title_sort regenerative medicine for oesophageal reconstruction after cancer treatment
publishDate 2015
url https://hdl.handle.net/10356/82779
http://hdl.handle.net/10220/25831
_version_ 1759854970022133760